VERDICT
Depends
Should I use Medidata?
Unified life sciences platform for clinical trials - medidata.com
· 1 month ago
Buy if you run regulated, multi-site clinical trials and can absorb enterprise pricing and implementation. Skip it for academic, pilot, or single Phase 1 studies — lighter EDC tools fit better.
Medium. Based on ~40 public sources; most review excerpts truncated; no public pricing figures found.
Not disclosed
high
Guess: validated study builds create lock-in; switching EDC mid-program is costly
medium
Quote-only enterprise pricing; expect long procurement cycles
medium
Early-stage sponsors need a separate Rave for Early-Stage Trials package
Value for money: 2/5
Rating
Not disclosed
Starting price
14
Sources
Analyzed
Not disclosed
No known vulnerabilities found in the sources reviewed.
Publishes SOC 2 Type II report, HDS-certified French hosting, EU-U.S. Data Privacy Framework policy.
G2 and Gartner reviews are broadly positive, while Reddit threads debate whether Rave's price and weight are justified.
Compare Medidata with each alternative.
Free/cheap academic EDC; fine for pilot and non-commercial studies
Lighter EDC; head-to-head G2 comparisons favor it
Budget-friendly EDC pitched at smaller trials
Comparable enterprise suite; common Medidata rival for big pharma
Based on ~40 public sources; most review excerpts truncated; no public pricing figures found.
Enterprise clinical-trial platform: right call for regulated Phase II-III sponsors, overkill for small or academic studies.
Based on ~40 public sources; most review excerpts truncated; no public pricing figures found.
Anonymous. You can change your vote.
Loading votes…
Comments
One queue. No nested comments. Give a display name first. Limit: 200 words per comment and 7 comments per day. You can edit or delete yours.
No comments yet.